Erratum: Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells Citation for this expression of concern (Journal of Clinical Investigation (2019) 129:8 (3464) Doi:10.1172/JCI131245)

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The corresponding author recently notified the JCI that the patient data presented in Figure 1B were not correct. Analysis of the correct patient data set does not show a significant difference in CERS6expression in human lung adenocarcinomas with positive invasive growth (definite) compared with those with negligible invasive growth or without invasive growth (focal/none). The Editors have requested an institutional investigation into this matter, and we will inform our readers of the outcome when the investigation is complete.

Cite

CITATION STYLE

APA

Suzuki, M., Cao, K., Kato, S., Komizu, Y., Mizutani, N., Tanaka, K., … Takahashi, T. (2019, August 1). Erratum: Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells Citation for this expression of concern (Journal of Clinical Investigation (2019) 129:8 (3464) Doi:10.1172/JCI131245). Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI131246

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free